Registered entities
Transine Therapeutics Limited
Reg. No. 11532498United Kingdom
Innovation
6 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 24 times.
| Year | Filings |
|---|---|
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Investor mix
10 investors on record; lead investors include Epidarex Capital, SV Health Investors, Takeda Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Other / undisclosed | 7 | 70% |